Showing results (111-120 of 288) with videos related to

Sort By:
Pageof 29
Microbial Drug Resistance (Larchmont, N.Y.)|July 1, 1995
Lower respiratory tract infections in the intensive care unit: consequences of antibiotic resistance for choice of antibioticH Lode, T Schaberg, M Raffenberg, et al.
Deutsche Medizinische Wochenschrift (1946)|October 17, 1975
[Pharmacokinetics and clinical observations of sisomicin, a newly developed aminoglycoside derivative (author's transl)]H Lode, B Kemmerich, P Koeppe, et al.
European Journal of Clinical Microbiology|February 1, 1983
Determination of cefmenoxime in human body fluids by high-performance liquid chromatographyK Borner, E Borner, H Lode, et al.
Clinical Pharmacokinetics|January 1, 1989
Unique aspects of quinolone pharmacokineticsH Lode, G Höffken, K Borner, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2002
Sparfloxacin as alternative treatment to standard therapy for community-acquired bacteremic pneumococcal pneumoniaH. Lode, M. Aubier, H. Portier, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1984
Comparative pharmacokinetics of apalcillin and piperacillinH Lode, A Elvers, P Koeppe, et al.
The European Respiratory Journal|September 1, 1991
Pulmonary schistosomiasis resembling acute pulmonary tuberculosisT Schaberg, W Rahn, P Racz, et al.
Immunitat Und Infektion|April 1, 1991
[Clinical aspects of endocarditis]H Lode, T Schaberg, G Höffken, et al.
Drugs|January 1, 1985
Pharmacokinetics of temocillin in volunteersB Hampel, M Feike, P Koeppe, et al.
Infection|January 1, 1982
[Clinical picture of Legionnaires' disease (author's transl)]H Lode, H Schäfer, R Schoeller, et al.
Pageof 29